4 ms·

Duty according to who? If he didn't raise the price by a factor of 4, you think shareholders could successfully sue?

• ilikehurdles 7y ago
  According to the very person the article is about: > "I think it is a moral requirement to make money when you can," Mulye told the Financial Times, "to sell the product for the highest price." For bonus points, it's coupled with > "I agree with Martin Shkreli that when he raised the price of his drug he was within his rights because he had to reward his shareholders," Mulye was quoted as saying. and > "I said I have to raise prices when I can -- how to get the best prices for my products, so that I can survive," Mulye told CNN. "It is about the survival of the business. It has nothing to do with morality." Frankly, every quote of the guy confirms further that he is a troll trying to emulate Trump's arrogance and stir shit up.
• yohannparis 7y ago
  To his shareholders. If a CEO I have shares into does not increase it's value, I don't think he is doing a good job. I'm not investing into company to make the world a better place, I vote and lobby government for this. Also, as long a drug companies customers are mostly health insurances and not the final users, you will never get real competition.